

(Alliance News) - Empiric Student Property PLC on Monday said meeting its full-year occupancy target will be "challenging" if market conditions do not...


(Alliance News) - BP PLC on Monday announced the USD1.5 billion sale of non-controlling interests in the Permian and Eagle Ford midstream assets of bp...


(Alliance News) - DCC PLC on Monday said it completed the divestment of its Info Tech business arm in the UK and Ireland to private equity investor Au...


(Alliance News) - BP sells stakes in US onshore midstream assets for USD1.5 billion, Empiric Student Property says it will be challenging to deliver i...


DUBAI, Nov 3 (Reuters) - Italy's Eni and Malaysia's state energy firm Petronas said on Monday they had signed a binding agreement to form a jointly ...


(Sharecast News) - BP has sold its non-controlling interests in the Permian and Eagle Ford midstream of its US onshore oil and gas division for $1.5bn...


LONDON, Oct 31 (Reuters) - A roller-coaster 2025 is entering its final weeks. The one-year anniversary of Donald Trump's victory in the U.S. preside...


(Sharecast News) - Industrial safety equipment maker Intertek Group on Monday said it had bought Suplilab, a provider of food safety and medical devic...


(Sharecast News) - Student accommodation provider Unite Group said on Monday that acquisition target Empiric Student Property had achieved occupancy o...


(Alliance News) - Stock prices in London closed mostly lower on Friday, after positive news for European trade with China and hawkish comments by a US...


(Sharecast News) - Shore Capital has raised its fair value target price for HSBC from 985p to 1,070p following the bank's better-than-expected third-q...




(Alliance News) - Stock prices in London were lower at midday on Friday, as shares in WPP continued to slide and weighed on the FTSE 100, threatening ...


(Alliance News) - Auto Trader PLC on Friday said its Chief Operating Officer Catherine Faiers is stepping down, as Moonpig PLC appointed her its new c...


(Alliance News) - AstraZeneca PLC on Thursday said phase 3 data regarding its investigational inhibitor gefurulimab met its primary endpoint in myasth...